Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 Stock Report

Market Cap: CN¥4.3b

Zhejiang Shouxiangu Pharmaceutical Future Growth

Future criteria checks 2/6

Zhejiang Shouxiangu Pharmaceutical is forecast to grow earnings and revenue by 19.4% and 16.1% per annum respectively. EPS is expected to grow by 18.8% per annum. Return on equity is forecast to be 13% in 3 years.

Key information

19.4%

Earnings growth rate

18.8%

EPS growth rate

Personal Products earnings growth26.4%
Revenue growth rate16.1%
Future return on equity13.0%
Analyst coverage

Low

Last updated25 Oct 2024

Recent future growth updates

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

Earnings and Revenue Growth Forecasts

SHSE:603896 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,090384N/A4252
12/31/2025972335N/A3822
12/31/2024871289N/A3252
9/30/2024714234-306263N/A
6/30/2024765265-365283N/A
3/31/2024799269-256286N/A
12/31/2023784254-99315N/A
9/30/2023864287-31316N/A
6/30/2023851286173318N/A
3/31/2023832281172339N/A
12/31/2022829278159341N/A
9/30/2022795244140334N/A
6/30/2022799228139339N/A
3/31/2022797219123310N/A
12/31/2021767201135297N/A
9/30/2021722172153281N/A
6/30/2021717164204300N/A
3/31/2021677160192284N/A
12/31/2020636152191256N/A
9/30/2020597134172241N/A
6/30/2020529119147209N/A
3/31/202051411396179N/A
12/31/2019547124116208N/A
9/30/201953110596191N/A
6/30/201953910090180N/A
3/31/2019550115-20186N/A
12/31/2018511108-61172N/A
9/30/201846198-75153N/A
6/30/2018430102N/A147N/A
3/31/2018409100N/A131N/A
12/31/201737089N/A111N/A
9/30/201734289N/A113N/A
6/30/201733385N/A100N/A
3/31/201731784N/A101N/A
12/31/201631581N/A96N/A
12/31/201530263N/A85N/A
12/31/201430269N/A103N/A
12/31/201325354N/A66N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603896's forecast earnings growth (19.4% per year) is above the savings rate (2.9%).

Earnings vs Market: 603896's earnings (19.4% per year) are forecast to grow slower than the CN market (25.8% per year).

High Growth Earnings: 603896's earnings are forecast to grow, but not significantly.

Revenue vs Market: 603896's revenue (16.1% per year) is forecast to grow faster than the CN market (14% per year).

High Growth Revenue: 603896's revenue (16.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603896's Return on Equity is forecast to be low in 3 years time (13%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y